Clinical Trial Update: Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of bryostatin and fludarabine in patients with chronic lymphocytic leukemia or relapsed indolent non-Hodgkin lymphoma, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Indolent Non-hodgkin Lymphoma

Drugs mentioned

• Bryostatin-1 (bryostatin-1)
• Fludarabine (Fludarabine)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Leukemia, Lymphoma | Phase 1 | Status: COMPLETED